Drug Discovery and Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Collaborations & Alliances | Drug Development
Jacobio Earns $20M AbbVie Milestone
Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.06.18.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eisai, BMS Enter Global Anticancer ADC Alliance
BMS to pay as much as $2.45B to co-develop Eisai’s MORAb-20206.18.21
-
Breaking News | Industry News | Laboratory Testing
-
cGMP Manufacture | Chemistry
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Sanofi Invests $425M in Flu Vaccine Manufacturing Facility
Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.06.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News
AbSci Acquires Cell Therapy Company Totient
Combination of Totient technology with AbSci's platform provides framework and data to enable in silico targeted drug design.06.17.21
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact
To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.06.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.06.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.06.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
VERAXA and Quadira Enter ADC Development Partnership
To develop a suite of novel ADCs for the treatment of oncological conditions.06.15.21
-
Capsules | Formulation Development
Formulation of Aqueous Core Poly(lactic acid) Microcapsules
This white paper demonstrates how single-step encapsulation of a water core can be achieved using Adare Pharma Solutions' Stratμm technology.
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Yposkesi to Build Second Commercial Bioproduction Site
Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings
Novavax COVID-19 Vax is 90% Effective in Phase 3 Trial
NVX-CoV2373 demonstrates 100% protection against moderate and severe disease, 90% efficacy overall, and met the primary endpoint.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance
GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Injectables
BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
Company now supplying more than 40 countries for pandemic vaccination campaigns.06.11.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
Third milestone payment related to the development of Oral KORSUVA.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
WuXi XDC and LegoChem Ink ADC Agreement
Sign MOU for the development and manufacturing of antibody-drug conjugates.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Vibalogics Expands Manufacturing Capacity
Invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors.06.11.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies
Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.06.10.21
-
Biologics, Proteins, Vaccines | Industry News
Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation
Doses to be donated to approximately 100 low- and lower middle-income countries.06.10.21
